| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Analysis of drug-drug interactions: an overview
|
Shipman Jr., Charles
|
|
1996
|
29 |
1 |
p. 41-43
3 p.
|
article
|
| 2 |
Cartesian coordinate analysis of viral burden and CD4 + cell count in HIV disease: implications for clinical trial design and analysis
|
Reichelderfer, P.S.
|
|
1996
|
29 |
1 |
p. 83-86
4 p.
|
article
|
| 3 |
CMV retinitis: ganciclovir/monoclonal antibody
|
Pollard, Richard B.
|
|
1996
|
29 |
1 |
p. 73-75
3 p.
|
article
|
| 4 |
Combination antiviral therapy for respiratory virus infections
|
Hayden, Frederick G.
|
|
1996
|
29 |
1 |
p. 45-48
4 p.
|
article
|
| 5 |
Combinations of ganciclovir and antibody for experimental CMV infections
|
Stals, Frans S.
|
|
1996
|
29 |
1 |
p. 61-64
4 p.
|
article
|
| 6 |
Combination therapy for HIV-1 infection-overview: preclinical and clinical analysis of antiretroviral combinations
|
Johnson, Victoria A.
|
|
1996
|
29 |
1 |
p. 35-39
5 p.
|
article
|
| 7 |
Combination therapy in primary HIV infection
|
Perrin, L.
|
|
1996
|
29 |
1 |
p. 87-89
3 p.
|
article
|
| 8 |
Combination therapy with zidovudine, didanosine and saquinavir
|
Collier, A.C.
|
|
1996
|
29 |
1 |
p. 99-
1 p.
|
article
|
| 9 |
Consensus symposium on combined antiviral therapy
|
Kern, Earl R.
|
|
1996
|
29 |
1 |
p. 3-
1 p.
|
article
|
| 10 |
Consensus symposium on combined antiviral therapy
|
de Jong, Menno D.
|
|
1996
|
29 |
1 |
p. 5-29
25 p.
|
article
|
| 11 |
Consensus symposium on combined antiviral therapy; Overview of interferon and IL-2 combinations for the treatment of HIV infection
|
Sneller, Michael C.
|
|
1996
|
29 |
1 |
p. 105-109
5 p.
|
article
|
| 12 |
Design of clinical trials for drug combinations: cytomegalovirus retinitis — foscarnet and ganciclovir. The CMV retinitis retreatment trial
|
Jabs, Douglas A.
|
|
1996
|
29 |
1 |
p. 69-71
3 p.
|
article
|
| 13 |
D4T nucleoside combinations for HIV
|
Pollard, Richard B.
|
|
1996
|
29 |
1 |
p. 101-104
4 p.
|
article
|
| 14 |
Editorial Board
|
|
|
1996
|
29 |
1 |
p. ii-
1 p.
|
article
|
| 15 |
Innovative combination clinical trial designs/patient compliance: A community perspective
|
Bahlman, William
|
|
1996
|
29 |
1 |
p. 115-117
3 p.
|
article
|
| 16 |
Inter-Company Collaboration for AIDS Drug Development: perspective on combination studies
|
McLaren, Colin
|
|
1996
|
29 |
1 |
p. 119-122
4 p.
|
article
|
| 17 |
In vitro antiviral activity of 141W94 (VX-478) in combination with other antiretroviral agents
|
St. Clair, M.H.
|
|
1996
|
29 |
1 |
p. 53-56
4 p.
|
article
|
| 18 |
In vitro evaluation of combination therapies against hepatitis B virus replication
|
Korba, Brent E.
|
|
1996
|
29 |
1 |
p. 49-51
3 p.
|
article
|
| 19 |
Overview: Issues concerning the pharmacology of multiple drug regimens
|
Lietman, Paul S.
|
|
1996
|
29 |
1 |
p. 65-
1 p.
|
article
|
| 20 |
Pilot clinical trial of the combination of hydroxyurea and didanosine in HIV-1 infected individuals
|
Biron, Francois
|
|
1996
|
29 |
1 |
p. 111-113
3 p.
|
article
|
| 21 |
Reduced sensitivity to saquinavir: an update on genotyping from phase I/II trials
|
Jacobsen, H.
|
|
1996
|
29 |
1 |
p. 95-97
3 p.
|
article
|
| 22 |
Role of animal models in selecting antiviral combinations for clinical studies
|
Kern, Earl R.
|
|
1996
|
29 |
1 |
p. 57-59
3 p.
|
article
|
| 23 |
Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4 + lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity
|
Vella, Stefano
|
|
1996
|
29 |
1 |
p. 91-93
3 p.
|
article
|
| 24 |
Summary: antiviral treatment of hepatitis C virus
|
Dusheiko, G.M.
|
|
1996
|
29 |
1 |
p. 77-82
6 p.
|
article
|
| 25 |
The implications of drug resistance for strategies of combination antiviral chemotherapy
|
Richman, Douglas D.
|
|
1996
|
29 |
1 |
p. 31-33
3 p.
|
article
|
| 26 |
Unique clinical trial design: combination acyclovir plus prednisone therapy of localized zoster in the normal host
|
Whitley, Richard J.
|
|
1996
|
29 |
1 |
p. 67-68
2 p.
|
article
|
| 27 |
Virus nomenclature
|
|
|
1996
|
29 |
1 |
p. 1-2
2 p.
|
article
|
Journal description